Alexander Tal
Endocrinology, Diabetes & Metabolism · Pittsburgh, PANPI 1306879374
Payments from drug & device makers
Across 277 payments — averaging $31.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corcept Therapeutics$3K
- Novo Nordisk$2K
- Lilly USA, LLC$566
- Sanofi-aventis U.S. LLC$498
- BD$345
- AstraZeneca$313
- plus $1K from 19 others
What the payments were for
- Consulting fees$3,87044%
- Travel & lodging$6768%
- Food & beverage$3,92945%
- Education$2293%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corcept Therapeutics | 11 | $3,085 |
| Novo Nordisk | 66 | $2,461 |
| Lilly USA, LLC | 35 | $566 |
| Sanofi-aventis U.S. LLC | 37 | $498 |
| BD | 17 | $345 |
| AstraZeneca | 16 | $313 |
| AbbVie | 13 | $224 |
| Merck | 18 | $205 |
| Amgen | 12 | $175 |
| Shire North American Group Inc | 12 | $157 |
| Insulet Corporation | 6 | $132 |
| Boehringer Ingelheim | 6 | $95 |
| Abbott | 5 | $79 |
| Johnson & Johnson | 3 | $55 |
| Vivus LLC | 3 | $43 |
| Aytu Biopharma, Inc. | 3 | $42 |
| Amarin Pharma, Inc. | 2 | $42 |
| Antares Pharma, Inc. | 2 | $35 |
| Lifescan, Inc. | 2 | $31 |
| Currax Pharmaceuticals LLC | 2 | $28 |
| IBSA Pharma Inc. | 2 | $28 |
| Pfizer | 1 | $23 |
| Medtronic | 1 | $16 |
| Strongbridge US Inc. | 1 | $14 |
| Radius Health, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,705 in reported general payments places this provider in the 70th percentile of 388 endocrinology, diabetes & metabolism providers in Pennsylvania.
See all endocrinology, diabetes & metabolism providers in Pennsylvania →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Novofine AutocoverPen Needle, Diabetic, Safety | 11 | $1,263 |
| Famotidine | 13 | $24 |
| Atorvastatin Calcium | 13 | $20 |
Paid to pharmacies, not to this prescriber.
Other endocrinology, diabetes & metabolism in Pittsburgh
- Vijay BahlPittsburgh$998K
- Erin KershawPittsburgh$804K
- Murray GordonPittsburgh$576K
- Swarna VarmaPittsburgh$520K
- Sachin BahlPittsburgh$162K
- Peter GrondziowskiPittsburgh$143K
- Patricia BononiPittsburgh$107K
- Frederico ToledoPittsburgh$92K
- Esra Karslioglu FrenchPittsburgh$73K
- Mona Al MukaddamPhiladelphia$3.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.